Lv11
24 积分 2026-01-31 加入
Protein Expression of PI3K/AKT/mTOR Pathway Targets Validated by Gene Expression and its Correlation with Prognosis in Canine Mammary Cancer
40分钟前
已完结
Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer Efficacy
18天前
已完结
Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expression
18天前
已完结
Discovery of 4‑Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis
25天前
已完结
Discovery of 4‑Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis
27天前
已完结
Discovery and Optimization of 2‑Amino-4-methylquinazoline Derivatives as Highly Potent Phosphatidylinositol 3‑Kinase Inhibitors for Cancer Treatment
28天前
已完结
Discovery and Optimization of Potent PROTAC Degraders of Phosphoinositide 3‑Kinase with Significant in Vivo Anticancer Efficacy
29天前
已完结
PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer
29天前
已完结
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation
29天前
已完结
Novel drug targets in 2025
1个月前
已完结
皖公网安备34019202002308
